Filing Details

Accession Number:
0001368148-22-000157
Form Type:
4
Zero Holdings:
No
Publication Time:
2022-11-22 15:53:56
Reporting Period:
2022-11-22
Accepted Time:
2022-11-22 15:53:56
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1368148 Athersys Inc / New ATHX Pharmaceutical Preparations (2834) 204864095
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1820365 A. Daniel Camardo 3201 Carnegie Ave
Cleveland OH 44115-2634
Ceo Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2022-11-22 100,000 $0.55 368,804 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Footnotes
  1. The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at $0.54 and $0.55. The reporting person undertakes to provide to Athersys, Inc., any security holder of Athersys, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.